Contract Research Organization Market Size 2024 to 2031

Increasing number of clinical trials resulting in increased outsourcing of clinical research organizationsThe number of clinical trials has increased sharply since the start of the pandemic. Clinical trials are an important process in developing new therapeutics or medical devices. One factor that may contribute to the failure of 90% of clinical trials is low drug exposure in the disease-targeted tissues. The increasing number of clinical trials, high cost of in-house drug development, and increasing investment in pharmaceutical RandD are encouraging pharma and biopharma companies to outsource. Outsourcing clinical trials allows pharmaceutical companies to avoid hiring, training, and overseeing clinical research staff. This increasing outsourcing of clinical research organizations is driving the market growth across the globe.

ID : IL_1494 | Language's : En/Jp/Fr/De | Publisher : IL | Format :